Physician profile
Randolph Hutter
NPI 1700047339
$778.19
in general payments reported to CMS, 2019-2025
12 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.14 · 2022: $11.25 · 2023: $294 · 2024: $311 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.68 | 2020-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $125.51 | 2024 | Opsumit, Uptravi |
| Philips North America LLC | $107.43 | 2023 | |
| Novartis Pharmaceuticals Corporation | $96.02 | 2023-2025 | |
| Abiomed | $82.86 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $46.86 | 2024 | Arcalyst |
| Boston Scientific Corporation | $29.27 | 2023 | Bodyguardian |
| E.R. Squibb & Sons, L.L.C. | $25.38 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals Lp | $25.28 | 2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.00 | 2024 | Jardiance |
| Amgen INC. | $21.85 | 2024 | Repatha |
| Pfizer INC. | $16.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Hutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.